BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 25151255)

  • 21. Lower Annual Rate of Progression of Short-Segment vs Long-Segment Barrett's Esophagus to Esophageal Adenocarcinoma.
    Hamade N; Vennelaganti S; Parasa S; Vennalaganti P; Gaddam S; Spaander MCW; van Olphen SH; Thota PN; Kennedy KF; Bruno MJ; Vargo JJ; Mathur S; Cash BD; Sampliner R; Gupta N; Falk GW; Bansal A; Young PE; Lieberman DA; Sharma P
    Clin Gastroenterol Hepatol; 2019 Apr; 17(5):864-868. PubMed ID: 30012433
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk stratification of patients with barrett's esophagus and low-grade dysplasia or indefinite for dysplasia.
    Thota PN; Lee HJ; Goldblum JR; Liu X; Sanaka MR; Gohel T; Kanadiya M; Lopez R
    Clin Gastroenterol Hepatol; 2015 Mar; 13(3):459-465.e1. PubMed ID: 25102445
    [TBL] [Abstract][Full Text] [Related]  

  • 23. To investigate outcomes in endoscopic management of early oesophageal adenocarcinoma in Barrett oesophagus: experience at three Australian tertiary centres.
    Pateria P; Chong A; Muwanwella N; Siah C; Kumarasinghe P; Raftopoulos S
    Intern Med J; 2022 Apr; 52(4):633-639. PubMed ID: 33073906
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association between length of Barrett's esophagus and risk of high-grade dysplasia or adenocarcinoma in patients without dysplasia.
    Anaparthy R; Gaddam S; Kanakadandi V; Alsop BR; Gupta N; Higbee AD; Wani SB; Singh M; Rastogi A; Bansal A; Cash BD; Young PE; Lieberman DA; Falk GW; Vargo JJ; Thota P; Sampliner RE; Sharma P
    Clin Gastroenterol Hepatol; 2013 Nov; 11(11):1430-6. PubMed ID: 23707463
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Endoscopic submucosal dissection is associated with less pathologic uncertainty than endoscopic mucosal resection in diagnosing and staging Barrett's-related neoplasia.
    Podboy A; Kolahi KS; Friedland S; Louie CY
    Dig Endosc; 2020 Mar; 32(3):346-354. PubMed ID: 31306525
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combined endoscopic mucosal resection and photodynamic therapy for esophageal neoplasia within Barrett's esophagus.
    Buttar NS; Wang KK; Lutzke LS; Krishnadath KK; Anderson MA
    Gastrointest Endosc; 2001 Dec; 54(6):682-8. PubMed ID: 11726842
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inter-Observer Variability in the Interpretation of Endoscopic Mucosal Resection Specimens of Esophageal Adenocarcinoma: Interpretation of ER specimens.
    Worrell SG; Boys JA; Chandrasoma P; Vallone JG; Dunst CM; Johnson CS; Lada MJ; Louie BE; Watson TJ; DeMeester SR
    J Gastrointest Surg; 2016 Jan; 20(1):140-4; discussion 144-5. PubMed ID: 26503261
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Impact of a Prior Diagnosis of Barrett's Esophagus on Esophageal Adenocarcinoma Survival.
    Tramontano AC; Sheehan DF; Yeh JM; Kong CY; Dowling EC; Rubenstein JH; Abrams JA; Inadomi JM; Schrag D; Hur C
    Am J Gastroenterol; 2017 Aug; 112(8):1256-1264. PubMed ID: 28374815
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Trimodal imaging-assisted endoscopic mucosal resection of early Barrett's neoplasia.
    Thomas T; Singh R; Ragunath K
    Surg Endosc; 2009 Jul; 23(7):1609-13. PubMed ID: 19296171
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk of neoplastic progression in Barrett's esophagus diagnosed as indefinite for dysplasia: a nationwide cohort study.
    Kestens C; Leenders M; Offerhaus GJ; van Baal JW; Siersema PD
    Endoscopy; 2015 May; 47(5):409-14. PubMed ID: 25521571
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Survival in esophageal high-grade dysplasia/adenocarcinoma post endoscopic resection.
    Qumseya BJ; Panossian AM; Rizk C; Cangemi DJ; Wolfsen C; Raimondo M; Woodward TA; Wallace MB; Wolfsen HC
    Dig Liver Dis; 2013 Dec; 45(12):1028-33. PubMed ID: 23938135
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Survival of patients with superficial esophageal adenocarcinoma after endoscopic treatment vs surgery.
    Ngamruengphong S; Wolfsen HC; Wallace MB
    Clin Gastroenterol Hepatol; 2013 Nov; 11(11):1424-1429.e2; quiz e81. PubMed ID: 23735443
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Early esophageal cancer in Europe: endoscopic treatment by endoscopic submucosal dissection.
    Probst A; Aust D; Märkl B; Anthuber M; Messmann H
    Endoscopy; 2015 Feb; 47(2):113-21. PubMed ID: 25479563
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Tissue Systems Pathology Test Detects Abnormalities Associated with Prevalent High-Grade Dysplasia and Esophageal Cancer in Barrett's Esophagus.
    Critchley-Thorne RJ; Davison JM; Prichard JW; Reese LM; Zhang Y; Repa K; Li J; Diehl DL; Jhala NC; Ginsberg GG; DeMarshall M; Foxwell T; Jobe BA; Zaidi AH; Duits LC; Bergman JJ; Rustgi A; Falk GW
    Cancer Epidemiol Biomarkers Prev; 2017 Feb; 26(2):240-248. PubMed ID: 27729357
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The prevalence of lymph node metastases in patients with T1 esophageal adenocarcinoma a retrospective review of esophagectomy specimens.
    Leers JM; DeMeester SR; Oezcelik A; Klipfel N; Ayazi S; Abate E; Zehetner J; Lipham JC; Chan L; Hagen JA; DeMeester TR
    Ann Surg; 2011 Feb; 253(2):271-8. PubMed ID: 21119508
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of endoscopic surveillance on mortality from Barrett's esophagus-associated esophageal adenocarcinomas.
    Corley DA; Mehtani K; Quesenberry C; Zhao W; de Boer J; Weiss NS
    Gastroenterology; 2013 Aug; 145(2):312-9.e1. PubMed ID: 23673354
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk of esophageal adenocarcinoma and mortality in patients with Barrett's esophagus: a systematic review and meta-analysis.
    Sikkema M; de Jonge PJ; Steyerberg EW; Kuipers EJ
    Clin Gastroenterol Hepatol; 2010 Mar; 8(3):235-44; quiz e32. PubMed ID: 19850156
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of EUS in patients with suspected Barrett's esophagus with high-grade dysplasia or early esophageal adenocarcinoma: impact on endoscopic therapy.
    Bartel MJ; Wallace TM; Gomez-Esquivel RD; Raimondo M; Wolfsen HC; Woodward TA; Wallace MB
    Gastrointest Endosc; 2017 Aug; 86(2):292-298. PubMed ID: 27889544
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Endoscopic mucosal resection versus esophagectomy for intramucosal adenocarcinoma in the setting of barrett's esophagus.
    Li C; Yamashita DT; Hawel JD; Bethune D; Henteleff H; Ellsmere J
    Surg Endosc; 2017 Oct; 31(10):4211-4216. PubMed ID: 28342132
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Effect of Endoscopic Surveillance in Patients With Barrett's Esophagus: A Systematic Review and Meta-analysis.
    Codipilly DC; Chandar AK; Singh S; Wani S; Shaheen NJ; Inadomi JM; Chak A; Iyer PG
    Gastroenterology; 2018 Jun; 154(8):2068-2086.e5. PubMed ID: 29458154
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.